These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24395713)

  • 1. SUMO Ubc9 enzyme as a viral target.
    Varadaraj A; Mattoscio D; Chiocca S
    IUBMB Life; 2014 Jan; 66(1):27-33. PubMed ID: 24395713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.
    Chen AJ; Gao L; Wang XW; Zhao XF; Wang JX
    J Virol; 2013 Jan; 87(1):636-47. PubMed ID: 23097446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent conjugation of the equine infectious anemia virus Gag with SUMO.
    Wang J; Wen S; Zhao R; Qi J; Liu Z; Li W; An J; Wood C; Wang Y
    Biochem Biophys Res Commun; 2017 May; 486(3):712-719. PubMed ID: 28342872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
    Li Z; Wu S; Wang J; Li W; Lin Y; Ji C; Xue J; Chen J
    Int J Mol Med; 2012 Nov; 30(5):1053-60. PubMed ID: 22895527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J; Goodson ML; Hong Y; Sarge KD
    J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
    Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
    Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9).
    Chiu MW; Shih HM; Yang TH; Yang YL
    J Biomed Sci; 2007 May; 14(3):429-44. PubMed ID: 17265167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
    Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
    Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
    Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
    EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
    Wu YC; Roark AA; Bian XL; Wilson VG
    Virology; 2008 Sep; 378(2):329-38. PubMed ID: 18619639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMOylation of nonstructural 5A protein regulates hepatitis C virus replication.
    Lee HS; Lim YS; Park EM; Baek SH; Hwang SB
    J Viral Hepat; 2014 Oct; 21(10):e108-17. PubMed ID: 24602294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
    Lin CH; Liu SY; Lee EH
    Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
    Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
    Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
    Niedenthal R
    Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1.
    Zhang Z; Liao B; Xu M; Jin Y
    FASEB J; 2007 Oct; 21(12):3042-51. PubMed ID: 17496161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
    Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
    EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An extended consensus motif enhances the specificity of substrate modification by SUMO.
    Yang SH; Galanis A; Witty J; Sharrocks AD
    EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.